PROVIDER PROFILE · NPI 1912989609

Carlos MatosMD

Internal MedicineSantarce, PRI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$6K

Peer benchmark

Total Medicare services vs. 426 Internal Medicine providers in PR — above median (cohort median 105).

PRESCRIBING · PART D · 2024

Total Rx claims

6,955

Beneficiaries

—

Total drug cost

$622K

Distinct drugs

Brand share

22.1%

Top prescribed drugs

Atorvastatin Calcium574 claims

Losartan Potassium399 claims

Levothyroxine Sodium371 claims

Levothyroxine Sodium330 claims

Simvastatin268 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$523

Payment records

By payment type

Food and Beverage$523

REFERRAL NETWORK

Where Carlos Matos's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
METRO SANTURCE, INC.	73	238
Daniel Mendez Diagnostic Radiology · Caguas, PR	24	89
Luis Garcia - Irizarry Diagnostic Radiology · San Juan, PR	14	37
Maximo Blondet Passalacqua Pulmonary Disease · San Juan, PR	12	26
Alexis Villalobos Diagnostic Radiology · Carolina, PR	11	36
Jose Caldera Nieves Internal Medicine · Guaynabo, PR	11	38
Libertad Montanez Internal Medicine · Santurce, PR	11	37

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history